Search research articles
Contact Us
Filters
Showing results (71-80 of 97) with videos related to
Page
of 10
Sort By:
JAAD International
|
August 19, 2021
Sex differences in factors associated with switch between systemic agents among individuals with psoriasis: A retrospective cohort study in Quebec, Canada
Raymond Milan, Jacques LeLorier, Marie-Josée Brouillette, et al.
Molecular Diagnosis & Therapy
|
January 31, 2023
A Cost-Effectiveness Analysis of Biomarkers for Risk Prediction in Atrial Fibrillation
Gisèle Nakhlé, Jean-Claude Tardif, Denis Roy, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
June 20, 2006
Cost effectiveness of the sirolimus-eluting stent in high-risk patients in Canada: an analysis from the C-SIRIUS trial
Stéphane Rinfret, David J Cohen, Amir A Tahami Monfared, et al.
The Canadian Journal of Cardiology
|
June 12, 2013
Atrial fibrillation and congestive heart failure: a cost analysis of rhythm-control vs. rate-control strategies
Frédéric Poulin, Paul Khairy, Denis Roy, et al.
Pharmacoepidemiology and Drug Safety
|
March 20, 2003
Bringing epidemiology into drug utilisation research
Jacques LeLorier, Robert H Vander Stichele, Jerry Avorn, et al.
Clinical Kidney Journal
|
June 16, 2017
The impact of renal protection clinics on prescription of and adherence to cardioprotective drug therapy in chronic kidney disease patients
Fanny Lepeytre, Héloise Cardinal, Lorraine Fradette, et al.
Current Medical Research and Opinion
|
March 5, 2008
Economic impact of generic substitution of lamotrigine: projected costs in the US using findings in a Canadian setting
Jacques LeLorier, Mei Sheng Duh, Pierre Emmanuel Paradis, et al.
JAAD International
|
August 23, 2022
Trajectories of systemic agent use and associated depression- and anxiety-related health care costs among patients with psoriasis
Raymond Milan, Jacques LeLorier, Eric A Latimer, et al.
The American Journal of Cardiology
|
January 25, 2011
Analysis of willingness to pay for implantable cardioverter-defibrillator therapy
Dominika Nowakowska, Jason R Guertin, Aihua Liu, et al.
The Canadian Journal of Cardiology
|
July 13, 2011
Atrial fibrillation: a real-life observational study in the Québec population
Jason R Guertin, Marc Dorais, Paul Khairy, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 97) with videos related to
Sort By:
Page
of 10
JAAD International
|
August 19, 2021
Sex differences in factors associated with switch between systemic agents among individuals with psoriasis: A retrospective cohort study in Quebec, Canada
Raymond Milan, Jacques LeLorier, Marie-Josée Brouillette, et al.
Molecular Diagnosis & Therapy
|
January 31, 2023
A Cost-Effectiveness Analysis of Biomarkers for Risk Prediction in Atrial Fibrillation
Gisèle Nakhlé, Jean-Claude Tardif, Denis Roy, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
June 20, 2006
Cost effectiveness of the sirolimus-eluting stent in high-risk patients in Canada: an analysis from the C-SIRIUS trial
Stéphane Rinfret, David J Cohen, Amir A Tahami Monfared, et al.
The Canadian Journal of Cardiology
|
June 12, 2013
Atrial fibrillation and congestive heart failure: a cost analysis of rhythm-control vs. rate-control strategies
Frédéric Poulin, Paul Khairy, Denis Roy, et al.
Pharmacoepidemiology and Drug Safety
|
March 20, 2003
Bringing epidemiology into drug utilisation research
Jacques LeLorier, Robert H Vander Stichele, Jerry Avorn, et al.
Clinical Kidney Journal
|
June 16, 2017
The impact of renal protection clinics on prescription of and adherence to cardioprotective drug therapy in chronic kidney disease patients
Fanny Lepeytre, Héloise Cardinal, Lorraine Fradette, et al.
Current Medical Research and Opinion
|
March 5, 2008
Economic impact of generic substitution of lamotrigine: projected costs in the US using findings in a Canadian setting
Jacques LeLorier, Mei Sheng Duh, Pierre Emmanuel Paradis, et al.
JAAD International
|
August 23, 2022
Trajectories of systemic agent use and associated depression- and anxiety-related health care costs among patients with psoriasis
Raymond Milan, Jacques LeLorier, Eric A Latimer, et al.
The American Journal of Cardiology
|
January 25, 2011
Analysis of willingness to pay for implantable cardioverter-defibrillator therapy
Dominika Nowakowska, Jason R Guertin, Aihua Liu, et al.
The Canadian Journal of Cardiology
|
July 13, 2011
Atrial fibrillation: a real-life observational study in the Québec population
Jason R Guertin, Marc Dorais, Paul Khairy, et al.
Page
of 10